**Question:** WHO guidelines to decrease both coronary heart disease and diabetes, triple treatment involves

**Core Concept:**
The question is about WHO guidelines that aim to reduce the risk of coronary heart disease (CHD) and diabetes by implementing triple treatment. Triple treatment refers to the simultaneous management of three key risk factors: hypertension, dyslipidemia, and diabetes. These risk factors contribute significantly to the development and progression of CHD and other cardiovascular diseases.

**Why the Correct Answer is Right:**
The correct answer involves the combination of three medications to manage these risk factors:

1. For hypertension (high blood pressure), Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin Receptor Blockers (ARBs) are commonly used. These medications help lower blood pressure by blocking the renin-angiotensin-aldosterone system (RAAS).
2. For dyslipidemia (unhealthy fats), statins are often prescribed. Statins inhibit the enzyme HMG-CoA reductase, which leads to reduced cholesterol synthesis and increased cholesterol uptake from the blood. This results in lowered LDL ("bad") cholesterol levels and improved cardiovascular outcomes.
3. For diabetes management, Metformin is a common choice. Metformin is a biguanide that helps reduce blood glucose levels by increasing insulin sensitivity in muscle cells, decreasing hepatic glucose production, and preserving beta-cell function.

**Why Each Wrong Option is Incorrect:**

A. Triple treatment without mentioning the specific medication for hypertension is incorrect, as ACEIs and ARBs are essential for managing hypertension.
B. Triple treatment without mentioning statins for dyslipidemia is incorrect, as statins are a crucial component in managing dyslipidemia and reducing cardiovascular risk.
C. Triple treatment without mentioning Metformin for diabetes is incorrect, as Metformin plays a vital role in managing diabetes and reducing the risk of cardiovascular complications.
D. Triple treatment without mentioning any medication is incorrect, as combining ACEIs/ARBs, statins, and Metformin is essential for addressing the three main risk factors mentioned in the question.

**Clinical Pearl:**
The implementation of triple treatment involving ACEIs/ARBs, statins, and Metformin not only addresses the three main risk factors (hypertension, dyslipidemia, and diabetes) but also contributes to a significant reduction in coronary heart disease and diabetes-related complications. This approach promotes optimal cardiovascular health and overall disease prevention.